Surgery Partners, Inc. 8K

Surgery Partners, Inc. furnished its Q2 2026 earnings presentation, reaffirming 2026 guidance and detailing financial results and the expected impact of divesting its Idaho Falls market facilities.

Surgery Partners, Inc. furnished an earnings presentation for the quarter and year-to-date period ended June 30, 2026, reporting modest same-facility surgical case growth, year-over-year revenue increases, and detailed Adjusted EBITDA performance, while reaffirming its full-year 2026 revenue and Adjusted EBITDA guidance and outlining the projected financial and business mix effects of a planned divestiture of its Idaho Falls market facilities, including reductions in Medicaid exposure, certain service lines, and non-surgical admissions. The presentation also provides a bridge from 2025 to the 2026 Adjusted EBITDA outlook, explains that the Idaho Falls divestiture is expected to be accretive to Adjusted EBITDA growth on a reported and organic basis, and reiterates the use of non-GAAP financial measures and forward-looking statements subject to various risks and uncertainties.

Filing Facts

CIK

1638833

Ticker

-

Form

8K

Source Type

sec

Accession

0001638833-26-000074

Alert Tier

7